KMS Medisurgi has informed that the compliance with the corporate governance provisions as specified in regulations 17, 12[17A,] 18, 19, 20, 21,22, 23, 24, 13[24A,] 25, 26, 27 and clauses (b) to (i) of sub-regulation (2) of regulation 46 and para C, D and E of Schedule V shall not apply, in respect of: the listed entity having paid up equity share capital not exceeding rupees ten crore and net worth not exceeding rupees twenty five crore, as on the last day of the previous financial year; and the listed entity which has listed its specified securities on the SME Exchange. As the Company has listed its shares on BSE SME Platform, so the above-mentioned provision will not be applicable to the Company and hence the Company is not required to disclose Related Party Transactions for the Half year ended 30th September, 2020 as provided under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.